Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
NIHR Open Research|November 15, 2024
An alcohol-related liver disease multi-stakeholder hub (ARMS-Hub) to enhance research activity in underserved communities in the UKAshwin Dhanda, Victoria Allgar, Neeraj Bhala, et al.Eclinicalmedicine|January 7, 2025
Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic reviewMohsan Subhani, Ashwin Dhanda, James A King, et al.The Lancet Regional Health. Europe|June 10, 2026
Implementation of evidence-based alcohol policies to reduce alcohol-related harm and liver disease to advance public health in EuropeElisa Pose, Luis Antonio Díaz, Richard Parker, et al.Alimentary Pharmacology & Therapeutics|November 18, 2022
The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for EnglandAshwin Dhanda, Keith Bodger, Steve Hood, et al.Alimentary Pharmacology & Therapeutics|July 18, 2019
Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitisEwan H Forrest, Natasha Storey, Rohit Sinha, et al.BMJ Open Gastroenterology|January 29, 2024
Mental Imagery to Reduce Alcohol-related harm in patients with alcohol use disorder and alcohol-related liver damaGE: the MIRAGE randomised pilot trial resultsAshwin Dhanda, Jackie Andrade, Hannah Allende, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2015
CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell ResponsesBaoying Liu, Ashwin Dhanda, Sima Hirani, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 31, 2021
Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic HepatitisRichard Parker, Joaquin Cabezas, Jose Altamirano, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2024
IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of CanakinumabNikhil Vergis, Vishal Patel, Karolina Bogdanowicz, et al.BMJ Open Gastroenterology|October 5, 2023
Quality standards for the management of alcohol-related liver disease: consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest groupRichard Parker, Michael Allison, Seonaid Anderson, et al.Pageof 2